bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.10.658848

Metadimensional simulation for biochemistry and pharmacology learning

Abstract

The integration of active learning strategies in health education is essential for improving student engagement and understanding, particularly in basic sciences like pharmacology and biochemistry. However, these disciplines are often perceived as abstract and disconnected from clinical practice. The aim was to develop and evaluate two innovative, live-action simulations for teaching fundamental concepts in pharmacokinetics and enzyme kinetics, using accessible materials and student-centered design. The study involved 305 students from health-related undergraduate and graduate programs. Two simulations were designed: a pharmacokinetics (PK) simulation representing systemic circulation and drug metabolism using plastic blocks and classroom stations; an enzyme kinetics (EK) simulation using both digital slides and physical block sets to model substrate-product reactions and construct Michaelis-Menten curves. Student perceptions were measured using a Likert-scale instrument adapted from validated educational models. Quantitative data (pharmacokinetic and enzymatic curves) were also generated from simulation outcomes. Students successfully built representative pharmacokinetic and enzymatic activity curves, allowing exploration of key concepts such as drug absorption, metabolism, Cmax, Tmax, half-life, and enzyme-substrate reaction rates. Perception surveys revealed high approval levels, particularly regarding the effectiveness, engagement, and collaborative aspects of the simulations. Over 85% of participants preferred the simulation-based approach over traditional lectures. These live-action activities represent a novel, effective, and low-cost strategy for enhancing the teaching of basic sciences in health education. The methods promote experiential learning, integrate cognitive, affective, and psychomotor domains, and foster student autonomy and motivation. These findings support the broader application of active methodologies in foundational science curricula.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Liguori, M. A. S., Aparicio, A. F., Rocha e Silva, T. A.. 2025-06-11. Metadimensional simulation for biochemistry and pharmacology learning. https://doi.org/10.1101/2025.06.10.658848

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration

Antisense oligonucleotides (ASOs) are a powerful therapeutic modality, but their full potential is hindered by pharmacokinetic properties that affect tissue and cellular delivery. Lipid conjugation is increasingly used to modulate ASO's biodistribution and promote extrahepatic activity, yet lipid dependent effects on in vivo functional delivery, particularly in the central nervous system (CNS), remain less explored. Here, we performed a side by side in vivo comparison of cholesterol, palmitic acid (C16:0), docosanoic acid (C22:0), and eicosapentaenoic acid (C20:5) conjugated to a fully phosphorothioated 3 10 3 LNA gapmer ASO targeting the Malat1 long non coding RNA. Lipid-ASO conjugates were administered systemically or locally in the brain of mice and evaluated for tissue level and cellular level distribution by imaging, qPCR and single-cell RNA sequencing, simultaneously annotating cell origin and global transcriptional changes within the cell. Following systemic administration in mice, lipid conjugation improved overall multi organ efficacy compared to unconjugated ASO, but with pronounced tissue specific differences. Single cell sequencing of liver and heart transcriptomes revealed lipid dependent cellular uptake patterns and transcriptional responses distinct from administration of unconjugated ASO. After intracerebroventricular administration, selected fatty acid conjugates enhanced silencing in deep brain regions such as the striatum, whereas cholesterol conjugation impaired functional delivery despite increased CNS retention. Light-sheet microscopy showed restricted parenchymal penetration of cholesterol ASOs compared with broader but heterogeneous distribution of palmitic acid conjugate. Together, these findings demonstrate that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context specific lipid design in ASO therapeutic development.

pharmacology and toxicology↗

Novel Dissymmetric Ionizable Lipid-Assembled Lipid Nanoparticles for Delivery of Ferroptosis-Related siRNA in Diabetic Treatment

Small interfering RNA (siRNA) enables precise post-transcriptional gene silencing for refractory diseases, yet its clinical translation remains limited by the lack of safe and efficient delivery vectors. Inspired by the dissymmetric alkyl chain architecture of natural membrane phospholipids, we designed and synthesized 34 novel ionizable lipids with dissymmetric hydrophobic tails and formulated them into lipid nanoparticles (LNPs). Through systematic physicochemical and biological assessments, we established clear structure-activity relationships and identified two lead LNPs (O14-LNP, H18a-LNP) with superior endosomal escape capacity, enhanced in vivo gene silencing potency, and favorable biosafety relative to the clinical benchmark MC3-LNP. In both streptozotocin-induced and spontaneous db/db type 2 diabetes (T2D) mouse models, lead LNPs delivering ferroptosis-related siRNAs effectively ameliorated glucose and lipid metabolic disorders, restored islet function, and alleviated hepatic steatosis. This study not only lays a theoretical foundation for the rational design of novel ionizable lipids, but also validates the therapeutic potential of siRNA therapy targeting ferroptosis, providing a versatile delivery platform and targeted therapeutic strategy for the treatment of T2D.

pharmacology and toxicology↗

Triclabendazole inhibits succinate dehydrogenase in vitro

Succinate dehydrogenase (SDH, complex II), is essential for mitochondrial respiration. This study shows that triclabendazole and its primary metabolites inhibit SDH activity in mitochondria of the cestode Echinococcus multilocularis, while other tested benzimidazoles do not. Further analyses revealed that triclabendazole and metabolites also inhibit SDH in mitochondria of additional helminths (trematodes, nematodes) and mammalian cells. These findings indicate a shared mode of action and highlight potential safety risks associated with long-term triclabendazole treatment in mammals.

pharmacology and toxicology↗